Successful TB vaccine moves forward after phase 2 trial
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted ...
Sep 29, 2020
0
3